Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals

Archives of Internal Medicine

Volumn 163, Issue 15, 2003, Pages 1813-1820

  Isetts, Brian J ^a   Brown, Lawrence M ^a   Schondelmeyer, Stephen W ^a   Lenarz, Lois A ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Fairview Health Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG COST; DRUG INDUCED DISEASE; FEMALE; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORBIDITY; PEER REVIEW; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; QUALITY CONTROL; SIDE EFFECT;

COOPERATIVE BEHAVIOR; DRUG THERAPY; HUMANS; PEER REVIEW, HEALTH CARE; PHARMACISTS; PHYSICIANS; QUALITY OF HEALTH CARE; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 0041653405     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.15.1813     Document Type: Article

References (40)

1. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000.
2. Richardson WC. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
3. Thompson CA. Physician leaders hear details on pharmacist collaborative drug therapy management. Am J Health Syst Pharm. 2001;58:843-846.
4. Ferro LA, Marcrom RE, Garrelts L, et al. Collaborative practice agreements between pharmacists and physicians. J Am Pharm Assoc (Wash). 1998;38:655-664.
5. Carmichael JM, O'Connell MB, Devine B, et al. Collaborative drug therapy management by pharmacists. Pharmacotherapy. 1997;17:1050-1061.
6. Manasse HR Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 1. Am J Hosp Pharm. 1989;46:929-944.
7. Manasse HR Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 2. Am J Hosp Pharm. 1989;46:1141-1152.
8. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995;155:1949-1956.
9. Bates DW, Cullen DJ, Laird N, et al, for the ADE Prevention Study Group. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274:29-34.
10. Leape LL, Bates DW, Cullen DJ, et al, for the ADE Prevention Study Group. Systems analysis of adverse drug events. JAMA. 1995;274:35-43.
11. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200-1205.
12. Gandhi TK, Burstin HR, Cook EF, et al. Drug complications in outpatients. J Gen Intern Med. 2000;15:149-154.
13. Bero LA, Lipton HL, Bird JA. Characterization of geriatric drug-related hospital readmission. Med Care. 1991;29:989-1003.
14. Hayward RA, Hofer TP. Estimating hospital deaths due to medical errors: preventability is in the eye of the reviewer. JAMA. 2001;286:415-420.
15. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001;41:192-199.
16. Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc. 1997;45:945-948.
17. Montamat SC, Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly. Clin Geriatr Med. 1992;8:143-158.
18. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice. New York, NY: McGraw-Hill Book Co; 1998.
19. Ebbesen J, Buajordet I, Erickson J, et al. Drug-related deaths in a department of internal medicine. Arch Intern Med. 2001;161:2317-2323.
20. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267-270.
21. Gurwitz JH, Rochon P. Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med. 2002;162:1670-1672.
22. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project impact: hyperlipidemia. J Am Pharm Assoc (Wash). 2000;40:157-173.
23. Hackbarth GM. Report to the Congress: Medicare Coverage of Nonphysician Practitioners. Washington, DC: Medicare Payment Advisory Commission; June 2002:21-26.
24. Hatoum HT, Akhras K. 1993 Bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Ann Pharmacother. 1993;27:1106-1119.
25. Schumock GT, Butler MG, Meek PD, Vermeulen LC, Bhakti-Arondekar MS, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy. 2003;23:113-132.
26. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 2002; issue 1.
27. Campagna KD. Pharmacists' levels of performance in making drug therapy decisions. Am J Health Syst Pharm. 1995;52:640-645.
28. Campagna KD, Newlin MH. Key factors influencing pharmacists' drug therapy decisions. Am J Health Syst Pharm. 1997;54:1307-1313.
29. Einarson TR, McGhan WF, Bootman JL. Decision analysis applied to pharmacy practice. Am J Hosp Pharm. 1985;42:364-371.
30. Mikeal RL, Brown TP, Lazarus HL, Vinson MC. Quality of pharmaceutical care in hospitals. Am J Hosp Pharm. 1975;32:567-574.
31. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533-543.
32. Rubin HR, Kahn KL, Rubenstein LV, Sherwood MJ. Guidelines for Structured Implicit Review of the Quality of Hospital Care for Diverse Medical and Surgical Conditions. Santa Monica, Calif: RAND Corp; 1990.
33. Pearson ML, Lee JL, Chang BL, Elliot M, Kahn KL, Rubenstein LV. Structured implicit review: a new method for monitoring nursing care quality. Med Care. 2000;38:1074-1091.
34. Goldman RL. The reliability of peer assessments: a meta-analysis. Eval Health Prof. 1994;17:3-21.
35. Goldman RL. The reliability of peer assessments of quality of care. JAMA. 1992; 267:958-60.
36. Localio AR, Weaver SL, Landis JR, et al. Identifying adverse events caused by medical care: degree of physician agreement in a retrospective chart review. Ann Intern Med. 1996;125:457-464.
37. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420-428.
38. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981.
39. Smith MA, Atherly AJ, Kane RL, Pacala JT. Peer review of the quality of care: reliability and sources of variability for outcome and process assessments. JAMA. 1997;278:1573-1578.
40. Zimmerman CR, Smolarek RT, Stevenson JG. Peer review and continuous quality improvement of pharmacists' clinical interventions. Am J Health Syst Pharm. 1997;54:1722-1727.